JP2015536337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536337A5 JP2015536337A5 JP2015540784A JP2015540784A JP2015536337A5 JP 2015536337 A5 JP2015536337 A5 JP 2015536337A5 JP 2015540784 A JP2015540784 A JP 2015540784A JP 2015540784 A JP2015540784 A JP 2015540784A JP 2015536337 A5 JP2015536337 A5 JP 2015536337A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- nucleic acid
- acid molecule
- erfe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261721322P | 2012-11-01 | 2012-11-01 | |
| US61/721,322 | 2012-11-01 | ||
| PCT/US2013/067771 WO2014071015A1 (en) | 2012-11-01 | 2013-10-31 | Erythroferrone and erfe polypeptides and methods of regulating iron metabolism |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015536337A JP2015536337A (ja) | 2015-12-21 |
| JP2015536337A5 true JP2015536337A5 (cg-RX-API-DMAC7.html) | 2016-12-22 |
| JP6501362B2 JP6501362B2 (ja) | 2019-04-17 |
Family
ID=50628048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540784A Expired - Fee Related JP6501362B2 (ja) | 2012-11-01 | 2013-10-31 | エリスロフェロンおよびｅｒｆｅポリペプチドならびに鉄代謝を調節する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160122409A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2914619B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6501362B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102186218B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104854130A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013337808B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015009954A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2890040A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2731609T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2684216C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014071015A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102405111B1 (ko) * | 2016-04-27 | 2022-06-02 | 블라디미르 바드마에브 | 쇼가올을 이용한 철 항상성 유지 방법 |
| WO2018027184A1 (en) * | 2016-08-05 | 2018-02-08 | Silarus Therapeutics, Inc. | Erfe specific antibodies compositions and methods of use |
| EP3519432A1 (en) * | 2016-10-03 | 2019-08-07 | Silarus Therapeutics, Inc. | Erfe fusion polypeptides compositions and methods of use |
| EP3595718A4 (en) * | 2017-03-13 | 2021-05-26 | Intrinsic LifeSciences LLC | ANTIBODIES DIRECTED AGAINST ERYTHROFERRONE AND THEIR USES |
| US11612595B2 (en) * | 2017-05-16 | 2023-03-28 | Generos Biopharma Ltd. | Compositions and methods for treating rheumatoid arthritis |
| US11255865B2 (en) | 2017-06-06 | 2022-02-22 | The Regents Of The University Of California | Immunoassay for human erythroferrone |
| TW201945026A (zh) * | 2018-01-29 | 2019-12-01 | 美商希拉諾斯醫療公司 | 結合erfe之抗體及使用方法 |
| WO2019212364A1 (en) * | 2018-05-01 | 2019-11-07 | Christopher Joseph Pemberton | Test for heart failure |
| CA3045370A1 (en) * | 2018-06-08 | 2019-12-08 | Pfizer Inc. | Methods of treating metabolic disease |
| US20220119516A1 (en) * | 2019-01-16 | 2022-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Variants of erythroferrone and their use |
| AU2020356575A1 (en) | 2019-09-27 | 2022-04-14 | Disc Medicine, Inc. | Methods for treating myelofibrosis and related conditions |
| EP4149548A4 (en) | 2020-05-13 | 2024-05-08 | Disc Medicine, Inc. | ANTI-HEMOJUVELIN ANTIBODIES (HJV) FOR THE TREATMENT OF MYELOFIBROSIS |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| EP4665354A1 (en) | 2023-02-13 | 2025-12-24 | Institut National de la Santé et de la Recherche Médicale | Methods of treatment of iron overload associated diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7749713B2 (en) * | 2002-11-19 | 2010-07-06 | Hasan Kulaksiz | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| GB0423973D0 (en) * | 2004-10-28 | 2004-12-01 | Ares Trading Sa | C1q related points |
| EP2335719B1 (en) * | 2005-02-16 | 2015-06-24 | The General Hospital Corporation | Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism |
| TW200900420A (en) * | 2007-02-02 | 2009-01-01 | Amgen Inc | Hepcidin, hepcidin antagonists and methods of use |
| GB0818273D0 (en) * | 2008-10-06 | 2008-11-12 | Cambridge Entpr Ltd | Modulation of cellular activity and differentiation |
| AU2009322260B2 (en) * | 2008-12-05 | 2013-09-12 | The Regents Of The University Of California | Mini-hepcidin peptides and methods of using thereof |
| WO2013112663A1 (en) * | 2012-01-26 | 2013-08-01 | The Johns Hopkins University | Myonectin (ctrp15), compositions comprising same, and methods of use |
-
2013
- 2013-10-31 EP EP13851277.7A patent/EP2914619B1/en not_active Not-in-force
- 2013-10-31 CN CN201380065041.2A patent/CN104854130A/zh active Pending
- 2013-10-31 KR KR1020157013416A patent/KR102186218B1/ko not_active Expired - Fee Related
- 2013-10-31 ES ES13851277T patent/ES2731609T3/es active Active
- 2013-10-31 RU RU2015120601A patent/RU2684216C2/ru active
- 2013-10-31 CA CA2890040A patent/CA2890040A1/en not_active Abandoned
- 2013-10-31 WO PCT/US2013/067771 patent/WO2014071015A1/en not_active Ceased
- 2013-10-31 JP JP2015540784A patent/JP6501362B2/ja not_active Expired - Fee Related
- 2013-10-31 AU AU2013337808A patent/AU2013337808B2/en not_active Ceased
- 2013-10-31 BR BR112015009954A patent/BR112015009954A2/pt not_active Application Discontinuation
-
2015
- 2015-04-28 US US14/698,608 patent/US20160122409A1/en not_active Abandoned
-
2018
- 2018-06-01 US US15/996,152 patent/US20180355008A1/en not_active Abandoned